| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |